David Domzalski
CIK 1727794 · PRESIDENT AND CEO · last filed 2026-07-24
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$198.3K
Companies
3
Total Filings
68
Lifetime Open-Market Net
-$10.3K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| VYNE | PRESIDENT AND CEO | 6,943 | $28.56 | $198.3K | $103.6K | 42 | 2026-07-24 |
| VYNE Therapeutics Inc. (MNLO) Delisted | President and CEO | 1,240,966 | — | — | $0 | 5 | 2020-07-02 |
| Foamix Pharmaceuticals Ltd. (FOMX) Delisted | CEO | 324,028 | — | — | -$113.9K | 20 | 2020-03-03 |
Recent Filings · Page 3 of 7
68 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-07-05 | VYNE | Tax (F) | −981 | -$4.0K | EDGAR |
| 2023-06-02 | VYNE | Grant (A) | +2,766 | $9.6K | EDGAR |
| 2023-04-04 | VYNE | Tax (F) | −2,734 | -$8.4K | EDGAR |
| 2023-01-04 | VYNE | Tax (F) | −10,685 | -$1.6K | EDGAR |
| 2022-12-02 | VYNE | Grant (A) | +34,705 | $6.9K | EDGAR |
| 2022-10-04 | VYNE | Tax (F) | −10,683 | -$2.4K | EDGAR |
| 2022-07-05 | VYNE | Tax (F) | −10,683 | -$4.2K | EDGAR |
| 2022-06-02 | VYNE | Grant (A) | +11,887 | $4.1K | EDGAR |
| 2022-04-04 | VYNE | Tax (F) | −23,186 | -$15.1K | EDGAR |
| 2022-03-18 | VYNE | Grant (A) | +312,302 | $0 | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.